Talcum Powder Cancer Lawsuit

Johnson & Johnson Is Forfeiting a Fortune By Discontinuing North American Sales of Baby Powder

As the saying goes, a billion here and a billion there and pretty soon you are talking about real money

Thursday, June 18, 2020 - News websites across the United States are incorrectly claiming that Johnson & Johnson are pulling their iconic brand of health care products from store shelves. The company is not withdrawing the product at all but discontinuing its productions and distributions. All existing bottles of Johnsons Baby Powder will remain for sale until all stocks have been sold. Johnson and Johnson claim that halting sales of Baby Powder is part of an overall company strategy to reposition itself to better manufacture products based on changing health care needs due to the Coronavirus. Baby Powder is only one of about 100 products, mostly first aid products and bandages where, not coincidentally, talc is also used. Johnson & Johnson continue to stand behind Johnson's Baby Powder as safe, pure, and asbestos-free.

The reasons Johnson & Johnson are giving for discontinuing sales of their iconic brand of baby powder seem ridiculous the more I think about it, as the company is forfeiting a not-so-small fortune every year in sales. New Brunswick Today defended the actions and placed the watershed event in the most favorable light. "Revenue from baby powder sales in the United States accounted for only about $1.5 billion in 2019, reportedly a small slice of some $82 billion in worldwide sales flow from J&Js consumer health segment. J&J said it would continue to vigorously defend the safety of the product, citing unfounded allegations associated with a myriad of cases it is up against in courtrooms, including the one downtown." The Record reported on the change in marketing strategy as if it were merely a routine event. The mere fact that the publication chose to focus on that slant leads one to question the reasons for deciding because so many of the other products included in the discontinuation notice were band-aids and bandage-related that include the use of talc also.

Rather than being part of an overall product group restructuring, it seems much more likely that Johnson & Johnson were trying to cut their losses as short as possible by discontinuing sales. Nearly 20,000 people with ovarian cancer or mesothelioma are blaming the product for causing their illness. You should contact a Johnsons Baby Powder cancer attorney to see if you qualify to file a claim against Johnson & Johnson if you have developed ovarian cancer or mesothelioma and have used Johnson's Baby Powder regularly and for many years.

Cosmetic industry experts think that the company is considering replacing talc, the main ingredient in Johnson's Baby Powder aside from some fragrance, with cornstarch due to consumers demanding less controversial ingredients other than talc with which to powder themselves and their babies. Cornstarch is cheaper and just as effective in absorbing moisture, holding a fragrance, and creating a smooth surface that reduces chaffing in between a baby's legs.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.